Steuer CE, Hayashi H, Su WC, Nishio M, et al. Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy. J Clin Oncol 2025 Jun 24:JCO2402744. doi: 10.1200/JCO-24-02744.
PMID: 40554742